Central Network Communications

Central Network Communications (CNC) was a specialized clinical trial service provider that focused on patient recruitment and retention for the pharmaceutical and biotechnology industries. Based in Horsham, Pennsylvania, the company developed data-driven strategies and utilized a proprietary network to help sponsors identify and enroll qualified participants for clinical studies. By optimizing the recruitment process, CNC aimed to reduce the time and cost associated with drug development across various therapeutic areas. In 2003, the company was acquired by Acurian, a leader in the patient recruitment sector, and its operations were integrated into Acurian's broader suite of clinical trial services. Following subsequent acquisitions, the legacy of CNC's expertise became part of PPD and eventually Thermo Fisher Scientific.